Viewing Study NCT00069992


Ignite Creation Date: 2025-12-24 @ 3:54 PM
Ignite Modification Date: 2025-12-26 @ 8:25 PM
Study NCT ID: NCT00069992
Status: TERMINATED
Last Update Posted: 2012-10-10
First Post: 2003-10-03
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Total-Body Irradiation, Fludarabine, and Alemtuzumab Followed By Stem Cell Transplant in Treating Patients With Myeloproliferative Disorder, MS, AML, or CML
Sponsor: Baylor College of Medicine
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module